Emergent BioSolutions Inc. — Director's Dealing 2014

Mar 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2014-03-11

Reporting Person: El-Hibri Fuad (Director, Chairman, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-11	Common Stock	A	56240	$0.00	Acquired	2146397	Direct
2014-03-11	Common Stock	F	1887	$28.09	Disposed	2144510	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-11	Stock Option (Right to Buy)	$28.09	A	112479	Acquired	2021-03-11	Common Stock (112479)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	127721	Indirect
Common Stock	13333	Indirect
Common Stock	13333	Indirect
Common Stock	1638403	Indirect
Common Stock	15845	Indirect
Common Stock	15845	Indirect
Common Stock	15845	Indirect
Common Stock	1524155	Indirect

Footnotes

F1: These restricted stock units vest in three equal annual installments beginning on the anniversary of the grant date, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F2: Mr. El-Hibri's direct holdings include restricted stock units granted under the 2nd Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan and the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.

F3: The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.

F4: These shares are held in a trust for the benefit of the reporting person's family. The reporting person's spouse is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F5: Mr. El-Hibri holds these shares with his wife, as tenants by the entirety.

F6: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F7: Mr. El-Hibri holds individually and with his wife, as tenants by the entirety, an aggregate 89.2% equity interest in Biovac, L.L.C. Biovac, L.L.C. is the direct owner of 1,524,155 shares of Common Stock. Mr. El-Hibri disclaims beneficial ownership of the shares of Common Stock directly owned by Biovac, L.L.C. for purposes of Section 16, except to the extent of his pecuniary interest in 1,359,546 shares.

F8: Vests in three equal installments on March 10, 2015, March 10, 2016 and March 10, 2017.